Catalent Inc
NYSE:CTLT
Catalent Inc
Other Operating Expenses
Catalent Inc
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Catalent Inc
NYSE:CTLT
|
Other Operating Expenses
-$145m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Operating Expenses
$1.7B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Operating Expenses
$2.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
57%
|
|
Pfizer Inc
NYSE:PFE
|
Other Operating Expenses
$1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
Merck & Co Inc
NYSE:MRK
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Catalent Inc's Other Operating Expenses?
Other Operating Expenses
-145m
USD
Based on the financial report for Dec 31, 2023, Catalent Inc's Other Operating Expenses amounts to -145m USD.
What is Catalent Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 1Y
-215%
Over the last year, the Other Operating Expenses growth was -215%.